Strafella R, Wang R, Petchpradub M, Sacknovitz A, McGoldrick P, Wolf S
Epilepsy Behav Rep. 2024; 28:100730.
PMID: 39691187
PMC: 11650214.
DOI: 10.1016/j.ebr.2024.100730.
Lewis K, Gudzune K, Ard J
Curr Obes Rep. 2024; 13(1):132-140.
PMID: 38172485
DOI: 10.1007/s13679-023-00546-9.
Gadde K, Atkins K
Expert Opin Pharmacother. 2020; 21(11):1319-1328.
PMID: 32292094
PMC: 7523877.
DOI: 10.1080/14656566.2020.1748599.
Haslam D
Int J Clin Pract. 2016; 70(3):206-17.
PMID: 26811245
PMC: 4832440.
DOI: 10.1111/ijcp.12771.
Chawla A, Carls G, Deng E, Tuttle E
Pharmacoeconomics. 2015; 33(7):749-63.
PMID: 26054325
DOI: 10.1007/s40273-015-0300-0.
Investigating interactions between phentermine, dexfenfluramine, and 5-HT2C agonists, on food intake in the rat.
Grottick A, Whelan K, Sanabria E, Behan D, Morgan M, Sage C
Psychopharmacology (Berl). 2014; 232(11):1973-82.
PMID: 25524140
PMC: 4425807.
DOI: 10.1007/s00213-014-3829-2.
New pharmacological treatments for the management of obesity.
Hurt R, Edakkanambeth Varayil J, Ebbert J
Curr Gastroenterol Rep. 2014; 16(6):394.
PMID: 24828101
DOI: 10.1007/s11894-014-0394-0.
Short-term outcomes of laparoscopic sleeve gastrectomy among obesity patients in the Northern West Bank: a retrospective records review.
Al Zabadi H, Daqour A, Hawari A, Hasouni J
BMC Res Notes. 2014; 7:85.
PMID: 24507561
PMC: 3921992.
DOI: 10.1186/1756-0500-7-85.
Impact of gastrointestinal surgery on cardiometabolic risk.
Moustarah F, Gilbert A, Despres J, Tchernof A
Curr Atheroscler Rep. 2012; 14(6):588-96.
PMID: 23054664
DOI: 10.1007/s11883-012-0288-2.
Novel strategy for the use of leptin for obesity therapy.
Tam C, Lecoultre V, Ravussin E
Expert Opin Biol Ther. 2011; 11(12):1677-85.
PMID: 21910668
PMC: 4220672.
DOI: 10.1517/14712598.2011.619974.
A cost-benefit analysis of bariatric surgery on the South Plains region of Texas.
Ewing B, Thompson M, Wachtel M, Frezza E
Obes Surg. 2010; 21(5):644-9.
PMID: 20852965
DOI: 10.1007/s11695-010-0266-0.
The economic impact of morbid obesity.
Frezza E, Wachtel M
Surg Endosc. 2009; 23(4):677-9.
PMID: 19184201
DOI: 10.1007/s00464-008-0325-y.
Appetite suppressants, cardiac valve disease and combination pharmacotherapy.
Rothman R, Baumann M
Am J Ther. 2008; 16(4):354-64.
PMID: 19092640
PMC: 2713386.
DOI: 10.1097/MJT.0b013e31817fde95.
Pharmacogenetics: potential role in the treatment of diabetes and obesity.
Vella A, Camilleri M
Expert Opin Pharmacother. 2008; 9(7):1109-19.
PMID: 18422469
PMC: 3901565.
DOI: 10.1517/14656566.9.7.1109.
The effect of Irvingia gabonensis seeds on body weight and blood lipids of obese subjects in Cameroon.
Ngondi J, Oben J, Minka S
Lipids Health Dis. 2005; 4:12.
PMID: 15916709
PMC: 1168905.
DOI: 10.1186/1476-511X-4-12.
Outcomes of pharmacological and surgical treatment for obesity.
Cerulli J, Malone M
Pharmacoeconomics. 1998; 14(3):269-83.
PMID: 10186466
DOI: 10.2165/00019053-199814030-00004.
Randomised controlled trial of novel, simple, and well supervised weight reducing diets in outpatients.
Summerbell C, Watts C, Higgins J, Garrow J
BMJ. 1998; 317(7171):1487-9.
PMID: 9831574
PMC: 28728.
DOI: 10.1136/bmj.317.7171.1487.
